ASEPTIC PROCESS
SIMULATION
(MEDIA FILL)
MANJULA GHOSH
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
AGENDA
1. DESCRIPTION AND PURPOSE OF APS
2. CONCEPTS, PRINCIPLES AND REGULATORY EXPECTATIONS
3. RISK ASSESSMENT AND WORST CASE SCENARIOS
4. STUDY DESIGN
5. DOCUMENTATION
6. POINTS TO CONSIDER – INTERVENTIONS.
7. INCUBATION, INSPECTION, ACCOUNTABILITY AND ACCEPTANCE CRITERIA
8. FAILURE INVESTIGATION
Disclaimer: The views and opinions expressed in this presentation are mine, and do not
necessarily reflect the views, opinions or official policy or position of my employer.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
WHAT IS ASEPTIC PROCESS SIMULATION (APS)?
 It is a tool to evaluate the capability of aseptic processing activities, using
microbiological growth promoting media in place of product. APS simulates
the aseptic process from the product and component sterilization to final
sealing of the container. The media is made to contact all product contact
surfaces of the equipment chain, container closure, critical environment and
process manipulations which the product itself will undergo.
 Media is then incubated and inspected for microbial growth. This information is
used to assess the potential for product units to become contaminated during
the aseptic processing operations.
ASEPTIC
PROCESS
SIMULATION
(MEDIA FILL)
PURPOSE OF MEDIA FILLS-
To assess the capability of the aseptic process to produce sterile
products reproducibly. Assess the contamination risk factors of the
process and hence the state of control.
Assess vulnerability to microbial contamination.
Demonstrate that the aseptic operating practices and procedures are
appropriate.
Evaluate the aseptic processing personnel practices.
Qualify/requalify/disqualify personnel.
Compliance with Good Manufacturing Practices and regulatory
expectations.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
CONCEPTS, PRINCIPLES AND REGULATORY EXPECTATIONS
NUMBER AND FREQUENCY OF APS
The number and type of APS should be based on Risk Assessment of the aseptic
process.
a. Qualification/validation of a new facility or new production process. APS is
performed after facility, process, equipment, facility decontamination, personnel
training, room qualification and EM program implementation is complete. APS is
one of the last steps in the validation process. Typically a minimum of three (3) APS
are a regulatory expectation.
b. Semi-annual APS are a regulatory expectation for a qualified line/ process.
c. Any major changes to facility or aseptic process – perform Risk Assessment to
determine if APS is needed and how many.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
RISK ASSESSMENT AND WORST CASE SCENARIOS
Definition of Risk – combination of a hazard and its likelihood of occurring
and harming the patient. In aseptic processing this is loss of sterility assurance.
 Risk assessment can be used to determine the worst case
manufacturing scenarios, holistic approach –
-operating conditions-including personnel
- interventions
- container closure – size and configuration
- line speed
- batch size
The Risk Assessment should be documented and used as the basis for the
design of the APS study.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
STUDY DESIGN
Ensure that the APS study/program incorporates risk factors and assesses the state of
process control. APS should simulate manufacturing operations including “worst case”
activities and conditions as identified during risk assessment. Some factors to be
simulated/evaluated during APS are
Aseptic Compounding
 The entire aseptic compounding process should be simulated including all aseptic
additions. APS can be stand alone for the compounding step or integrated with
filling.
 Filling
 Longest duration of run on an aseptic processing line.
 Interventions – inherent (routine) and corrective (non-routine)
 Aseptic assembly-line set up
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
 Number of personnel – duration and activities, shift changes, breaks
 Number of aseptic additions/transfers
 Connections/disconnections
 Processes such as Lyophilization
 Line speed and configuration
 Container closure types/systems
 Inert gassing
 Number of units filled
 Frequency and number of runs
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
DOCUMENTATION
Documentation of every step of the APS is very important. The documentation
will serve as record of the rationale for APS design and it’s performance.
Documentation should include step by step instructions of the performance of
the APS, acceptance criteria, all results obtained, any deviation.
An aseptic simulation policy/procedure should be prepared which gives an
overall comprehensive list of requirements and rationale for APS studies.
The following documentation procedure is recommended.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
PROTOCOL
 An approved APS protocol should be in place prior to starting the study.
Information/instructions in the protocol should include at a minimum
 Responsible groups for execution, testing
 Rationale for “worst case” scenarios
 Identification of room, filling line, equipment, process flow.
 Types of container closure to be used
 Fill volume
 Minimum number of units to be filled and rationale
 Line speed(s)
 Type of media to be used with rationale
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
 Number and types of interventions
 Number, identity and roles of personnel
 Environmental monitoring to be performed
 Accountability of units filled
 Incubation conditions and durations
 Inspection of units – pre-incubation, post incubation and intermediate
 Acceptance criteria
 Conditions of exclusion of vials from incubation (this should be rare)
 Growth promotion
 Conditions for invalidating/cancelling – decision making authority
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
 Personnel training requirements
 Details about batch record to be used
 Documentation requirements for the final report
Batch Record
A detailed batch record (BR) written in the same format as the production BR with the
same data recording and verification/sign off requirements should be in place.
An additional section detailing the step by step performance of the Interventions should
be a part of this BR. All interventions performed (planned and unplanned)with details such
as time, operators involved, duration, the identity of the tray filled, any line stoppages,
sample units removed, should be clearly documented.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
All results should be a part of the batch record including –
 Environmental and personnel Monitoring results
 Number of units filled, number of units incubated, full accountability
 Number of units rejected pre-incubation with cause for rejection
 Results of inspection – number of units positive for growth, tray identity, detailed
investigation with root cause and corrective/preventive actions
 Growth Promotion of media after incubation
 Record of activities and occurrences during the APS
 Any deviations/OOS
 A Final Report which evaluates the entire media fill and formulates a conclusion on the
acceptability of the APS is required.
 Quality unit oversight of the entire process including observation in real time
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
POINTS TO CONSIDER FOR APS
1. Number of APS – for new line/process a minimum of three (3) APS are required. For
ongoing requalification – minimum semi-annual. If different processes are performed
on the same line, each process has to be re-evaluated semi-annually.
2. Container closure – if multiple sizes of containers of the same type and in same process
are used, a bracketing approach (smallest-largest) may be used.
3. Filling speed-generally should be set at production filling range. However if higher or
lower speeds present “worst case” conditions those maybe used. Eg. Bracketing
approach of highest speed with smallest unit (operational challenge-PM generation) or
slowest speed with largest vial (larger neck size – maximum exposure) may be used.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
4. Fill volume- container need not be filled to full capacity. Amount of
media should be sufficient to contact all container –closure surfaces
when inverted and allow for detection of microbial growth.
5. Media used – most common medium used is Soybean Casein Digest
Medium (SCDM). This medium is capable of supporting the growth of
aerobic microorganisms commonly found in the clean room environment
and personnel samples. If the process being validated is anaerobic then
Fluid Thioglycollate Medium (FTM) may be used.
6. Inert gassing – Typically Nitrogen or other inert gases are used to protect
oxygen-sensitive products and also to provide positive pressure for
transfer. For APS the Nitrogen should be replaced by air using the same
method of delivery and at the same steps.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Duration and number of units filled – the duration should simulate the longest fill or be
representative of routine operations. The duration should be sufficient to allow all
interventions and process steps to be executed. Number of units filled during APS should be
based on contamination risk and sufficient to simulate the process. Generally 5,000-10,000
units are considered acceptable for average production runs.
 For production batches less than 5,000 units, the APS batch should be equal to the
production batch size.
 For production batches 5,000 to 10,000 units, the APS batch should be comparable size
(5,000-10,000 units).
 For production batches >10,000 units, the APS batch should be > 10,000 units with several
approaches to the batch size and filling process.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Interventions-
Activities performed by personnel in proximity to the aseptic fill zone are
called Interventions. Some of these are unavoidable and part of the process.
However, Interventions in aseptic processes should be kept to a minimum. The
Risk Assessment performed should be used to record and evaluate the
contamination risk posed to the product due to each intervention.
 Identification of Interventions- the type and frequency of each intervention
must be identified. Hence a list of interventions with the frequency of
occurrence is to be maintained and re-evaluated.
 The interventions are grouped into two categories – inherent (routine) and
corrective (non-routine).
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Inherent (routine) Interventions-
 These are normal planned activities that occur during an aseptic
filling process. Some examples are
 Equipment set up – aseptic assembly
 Fill weight checks and adjustments
 Recharging stoppers and other closures
 Environmental Monitoring sampling
 Shift changes, breaks, duration of personnel activity
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Corrective (non-routine) interventions
These are performed to correct an aseptic process during execution. They are not a
part of the normal aseptic process but they are well defined and recognized as
occurring on infrequent occasions. Some examples-
 Container breakage and picking up fallen units
 Correcting stopper jams
 Changing out filling needles or equipment
 Pulling samples
 Clearing rejected units
 Maintenance work – line stoppage
 Changing out of filters, tubing, pumps
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
List and process for Interventions-
There should be an approved list of interventions. This list is to be re-evaluated at pre-
determined intervals or if any unusual events occur during production runs.
There should be established procedures that describe how to perform these interventions.
Only personnel trained/qualified in the interventions should be permitted to perform them.
During an APS these interventions should be incorporated to represent the type and
frequency of each type on the approved list.
During routine production operations, any interventions performed should be documented
and frequency noted. If any unusual interventions are performed they should be evaluated
and a Risk Assessment performed as necessary. Based on the risk/evaluation they should be
incorporated into the approved list of interventions for APS.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
PROCESS QUALIFICATION
Lyophilized Products – most are aseptically filled and then transferred to a pre-sterilized
lyophilization chamber and subject to lyophilization.
The process of loading the partially stoppered units into the lyophilizer, lyophilization process
and the final unloading of the chamber must be captured during an APS. This can be done as
follows-
 Load /unload with shortened hold time and partial vacuum.
 Simulated lyophilization- where the units are held under partial vacuum for the full duration of
the cycle.
 In both cases sterile air is used to vent the chamber instead of Nitrogen.
 APS is used to qualify and requalify the aseptic steps of the lyophilization process.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
PERSONNEL QUALIFICATION
The requirements and the process for the qualification of personnel should be documented in
a procedure and results documented and records maintained per each person.
Pre-requisite – all relevant training such as gowning qualification, clean room and aseptic
behavior training, GMP training, procedure training,
Initial Qualification- Personnel should participate in a successful APS in which they perform
activities which they would normally perform.
Periodic Qualification- Personnel should participate in a successful APS in which they perform
activities which they would normally perform once per year at a minimum.
Disqualification can occur if the personnel fail to participate in periodic qualification, fail
gown certification repeatedly, participate in a failed APS whose failure was directly attributed
to their poor aseptic technique.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Pre-incubation inspection
After the completion of the filling and sealing process, the exact unit count is
recorded and verified.
The units are subject to pre-incubation inspection. The purpose is to remove all
non-integral units which would have been removed during normal product
inspection. Once again count of units proceeding for incubation is documented
and verified.
Some examples of units which maybe removed are units with cracks, misaligned
or missing stoppers, poor crimps- units with compromised container closures.
These would also be removed during routine inspection of product.
No unit maybe removed due to cosmetic defects.
The number of units removed and the cause should be documented and verified.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Incubation conditions
Incubation conditions should be suitable for the recovery of bioburden and
environmental isolates. It should be in the range of 20-350 C.
Incubation time should be not less than 14 days.
A single incubation temperature for 14 days or two temperatures for 7 days
each may be used. If two incubation temperatures are used it is
recommended to start incubation at the lower temperature.
Prior to start of incubation all units should be inverted or manipulated so that
the media comes into contact with all internal surfaces.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Post –incubation inspection
After completion of incubation, all APS units are inspected visually for the
presence of microbial growth.
Personnel trained to detect low/high levels and different types of microbial growth
should perform the inspection.
The count of units is performed and verified after inspection.
If non-integral units are found an investigation should be performed as these
should have been detected during pre-incubation inspection.
All these activities should have the oversight of the Quality unit.
Growth Promotion should be performed after final inspection. In addition to ATCC
cultures the most common environmental isolates should be used.
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Acceptance Criteria
The target acceptance criteria for APS study is zero contaminated units.
Per FDA Guidance for Aseptic Processing
When filling <5000 units – one contaminated unit is cause for revalidation
When filling 5000 to 10,000 units-
- one contaminated unit – investigation and possible repeat media fill
- two contaminated units- revalidation following investigation
When filling > 10,000 units-
- one contaminated unit – investigation
- two contaminated units- revalidation following investigation
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
Investigation of an APS positive/contamination
A thorough investigation should be performed and documented with root cause and
corrective/preventive actions clearly identified. At a minimum, the investigation should include the
following-
 Species level identification of the contaminant and comparison to EM/personnel isolates
 Holistic look at all systems and engineering controls
 Environmental trend and recovery review
 Personnel activities and qualification
 Sanitization process review
 Review of batch record, sterilization processes and any deviations
 Tracing the location of the contaminant and corelating to any interventions
 Trend review of previous APS
ASEPTIC PROCESS SIMULATION
(MEDIA FILL)
REFERENCES
1. FDA Guidance for Industry- “Sterile Drug Products Produced by Aseptic
Processing – Current Good Manufacturing Practices.” September 2004.
2. PDA Technical Report No. 22 – “Process Simulation for Aseptically Filled
Products.” 2011.
3. EU GMP Annex 1: Manufacture of Sterile Medicinal Products. 2009
(EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
Guidelines to Good Manufacturing Practice Medicinal Products for Human and
Veterinary Use)

More Related Content

PPT
Control on Cleanroom Environmental Monitoring (Pharmaceutical)
PPTX
Environmental monitoring - nonviable particle testing
PDF
Computer System Validation - The Validation Master Plan
PDF
Zablocki, Shawn, Olsson Associates, Mechanical Integrity Programs for MRP and...
PPT
ENVIRONMENTAL MONITORING
PPTX
Environmental monitoring - Introduction
PPTX
EU GMP Annex1 Review
PPTX
Standard operating procedures (SOPs)
Control on Cleanroom Environmental Monitoring (Pharmaceutical)
Environmental monitoring - nonviable particle testing
Computer System Validation - The Validation Master Plan
Zablocki, Shawn, Olsson Associates, Mechanical Integrity Programs for MRP and...
ENVIRONMENTAL MONITORING
Environmental monitoring - Introduction
EU GMP Annex1 Review
Standard operating procedures (SOPs)

What's hot (20)

PPTX
Standard Operating procedure
PPTX
Aseptic filling
PPTX
USP &lt;1116> and its impact on Microbiology
PDF
Product Quality Review_APQR_Dr. A. Amsavel
PPTX
GMP Training: Handling of deviation
PPTX
Auditing of sterile poduction
PPT
Good documentation practice
PDF
Process Flow of Pharma Companies
PDF
Sop 820 capa procedure corrective preventive action med dev
PPTX
Good Documentation Practices -Do's and Don'ts- (GCP)
PPTX
Deviation and root cause analysis in Pharma
PPT
Quality audit slideshare
PPT
PPT
STERILE PROCESS OF VALIDATION
PDF
Process Validation Guidances FDA and Global
PPT
Audit Check List
PPT
Cleaning validation
Standard Operating procedure
Aseptic filling
USP &lt;1116> and its impact on Microbiology
Product Quality Review_APQR_Dr. A. Amsavel
GMP Training: Handling of deviation
Auditing of sterile poduction
Good documentation practice
Process Flow of Pharma Companies
Sop 820 capa procedure corrective preventive action med dev
Good Documentation Practices -Do's and Don'ts- (GCP)
Deviation and root cause analysis in Pharma
Quality audit slideshare
STERILE PROCESS OF VALIDATION
Process Validation Guidances FDA and Global
Audit Check List
Cleaning validation
Ad

Similar to aseptic-process-simulation-(media-fill).pdf (20)

PPTX
Aseptic Media Fill Validation.pptx
PPT
Media fill process and validation
PDF
Basics of Preparing an Air Emissions Inventory
PDF
What is HAZOP?
PPT
Pilot scaleuptechnique
PPT
Pilot plant scaleuptechnique
PPT
Pilot scaleuptechnique
PDF
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
PDF
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
PDF
Update on-pda-tr22-revisions-for-aseptic-process-simulations
PDF
industrial safety and hazar
PPT
Anthony crasto scaleup techniques & pilot plant
DOCX
Hazop analysis complete report
PPT
HAZOP AND OPERABILITY STUDY
PPTX
HAZOP ppt for chambal urea -1.pptx
PPT
Pilot plant scale up techniques
PPTX
A real-world introduction to PSM’s 14 Elements
PPTX
Preformulation
PDF
483 case study
Aseptic Media Fill Validation.pptx
Media fill process and validation
Basics of Preparing an Air Emissions Inventory
What is HAZOP?
Pilot scaleuptechnique
Pilot plant scaleuptechnique
Pilot scaleuptechnique
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Scale Up Methodology for the Fine Chemical Industry - The Influence of the Mi...
Update on-pda-tr22-revisions-for-aseptic-process-simulations
industrial safety and hazar
Anthony crasto scaleup techniques & pilot plant
Hazop analysis complete report
HAZOP AND OPERABILITY STUDY
HAZOP ppt for chambal urea -1.pptx
Pilot plant scale up techniques
A real-world introduction to PSM’s 14 Elements
Preformulation
483 case study
Ad

Recently uploaded (20)

PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
Transcultural that can help you someday.
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPT
Infections Member of Royal College of Physicians.ppt
PPT
Dermatology for member of royalcollege.ppt
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPTX
Acute Coronary Syndrome for Cardiology Conference
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPTX
Wheat allergies and Disease in gastroenterology
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PDF
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PDF
Calcified coronary lesions management tips and tricks
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PDF
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
OSCE Series Set 1 ( Questions & Answers ).pdf
Transcultural that can help you someday.
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Infections Member of Royal College of Physicians.ppt
Dermatology for member of royalcollege.ppt
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
Acute Coronary Syndrome for Cardiology Conference
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
Wheat allergies and Disease in gastroenterology
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
Approach to chest pain, SOB, palpitation and prolonged fever
Calcified coronary lesions management tips and tricks
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf

aseptic-process-simulation-(media-fill).pdf

  • 2. ASEPTIC PROCESS SIMULATION (MEDIA FILL) AGENDA 1. DESCRIPTION AND PURPOSE OF APS 2. CONCEPTS, PRINCIPLES AND REGULATORY EXPECTATIONS 3. RISK ASSESSMENT AND WORST CASE SCENARIOS 4. STUDY DESIGN 5. DOCUMENTATION 6. POINTS TO CONSIDER – INTERVENTIONS. 7. INCUBATION, INSPECTION, ACCOUNTABILITY AND ACCEPTANCE CRITERIA 8. FAILURE INVESTIGATION Disclaimer: The views and opinions expressed in this presentation are mine, and do not necessarily reflect the views, opinions or official policy or position of my employer.
  • 3. ASEPTIC PROCESS SIMULATION (MEDIA FILL) WHAT IS ASEPTIC PROCESS SIMULATION (APS)?  It is a tool to evaluate the capability of aseptic processing activities, using microbiological growth promoting media in place of product. APS simulates the aseptic process from the product and component sterilization to final sealing of the container. The media is made to contact all product contact surfaces of the equipment chain, container closure, critical environment and process manipulations which the product itself will undergo.  Media is then incubated and inspected for microbial growth. This information is used to assess the potential for product units to become contaminated during the aseptic processing operations.
  • 4. ASEPTIC PROCESS SIMULATION (MEDIA FILL) PURPOSE OF MEDIA FILLS- To assess the capability of the aseptic process to produce sterile products reproducibly. Assess the contamination risk factors of the process and hence the state of control. Assess vulnerability to microbial contamination. Demonstrate that the aseptic operating practices and procedures are appropriate. Evaluate the aseptic processing personnel practices. Qualify/requalify/disqualify personnel. Compliance with Good Manufacturing Practices and regulatory expectations.
  • 5. ASEPTIC PROCESS SIMULATION (MEDIA FILL) CONCEPTS, PRINCIPLES AND REGULATORY EXPECTATIONS NUMBER AND FREQUENCY OF APS The number and type of APS should be based on Risk Assessment of the aseptic process. a. Qualification/validation of a new facility or new production process. APS is performed after facility, process, equipment, facility decontamination, personnel training, room qualification and EM program implementation is complete. APS is one of the last steps in the validation process. Typically a minimum of three (3) APS are a regulatory expectation. b. Semi-annual APS are a regulatory expectation for a qualified line/ process. c. Any major changes to facility or aseptic process – perform Risk Assessment to determine if APS is needed and how many.
  • 6. ASEPTIC PROCESS SIMULATION (MEDIA FILL) RISK ASSESSMENT AND WORST CASE SCENARIOS Definition of Risk – combination of a hazard and its likelihood of occurring and harming the patient. In aseptic processing this is loss of sterility assurance.  Risk assessment can be used to determine the worst case manufacturing scenarios, holistic approach – -operating conditions-including personnel - interventions - container closure – size and configuration - line speed - batch size The Risk Assessment should be documented and used as the basis for the design of the APS study.
  • 7. ASEPTIC PROCESS SIMULATION (MEDIA FILL) STUDY DESIGN Ensure that the APS study/program incorporates risk factors and assesses the state of process control. APS should simulate manufacturing operations including “worst case” activities and conditions as identified during risk assessment. Some factors to be simulated/evaluated during APS are Aseptic Compounding  The entire aseptic compounding process should be simulated including all aseptic additions. APS can be stand alone for the compounding step or integrated with filling.  Filling  Longest duration of run on an aseptic processing line.  Interventions – inherent (routine) and corrective (non-routine)  Aseptic assembly-line set up
  • 8. ASEPTIC PROCESS SIMULATION (MEDIA FILL)  Number of personnel – duration and activities, shift changes, breaks  Number of aseptic additions/transfers  Connections/disconnections  Processes such as Lyophilization  Line speed and configuration  Container closure types/systems  Inert gassing  Number of units filled  Frequency and number of runs
  • 9. ASEPTIC PROCESS SIMULATION (MEDIA FILL) DOCUMENTATION Documentation of every step of the APS is very important. The documentation will serve as record of the rationale for APS design and it’s performance. Documentation should include step by step instructions of the performance of the APS, acceptance criteria, all results obtained, any deviation. An aseptic simulation policy/procedure should be prepared which gives an overall comprehensive list of requirements and rationale for APS studies. The following documentation procedure is recommended.
  • 10. ASEPTIC PROCESS SIMULATION (MEDIA FILL) PROTOCOL  An approved APS protocol should be in place prior to starting the study. Information/instructions in the protocol should include at a minimum  Responsible groups for execution, testing  Rationale for “worst case” scenarios  Identification of room, filling line, equipment, process flow.  Types of container closure to be used  Fill volume  Minimum number of units to be filled and rationale  Line speed(s)  Type of media to be used with rationale
  • 11. ASEPTIC PROCESS SIMULATION (MEDIA FILL)  Number and types of interventions  Number, identity and roles of personnel  Environmental monitoring to be performed  Accountability of units filled  Incubation conditions and durations  Inspection of units – pre-incubation, post incubation and intermediate  Acceptance criteria  Conditions of exclusion of vials from incubation (this should be rare)  Growth promotion  Conditions for invalidating/cancelling – decision making authority
  • 12. ASEPTIC PROCESS SIMULATION (MEDIA FILL)  Personnel training requirements  Details about batch record to be used  Documentation requirements for the final report Batch Record A detailed batch record (BR) written in the same format as the production BR with the same data recording and verification/sign off requirements should be in place. An additional section detailing the step by step performance of the Interventions should be a part of this BR. All interventions performed (planned and unplanned)with details such as time, operators involved, duration, the identity of the tray filled, any line stoppages, sample units removed, should be clearly documented.
  • 13. ASEPTIC PROCESS SIMULATION (MEDIA FILL) All results should be a part of the batch record including –  Environmental and personnel Monitoring results  Number of units filled, number of units incubated, full accountability  Number of units rejected pre-incubation with cause for rejection  Results of inspection – number of units positive for growth, tray identity, detailed investigation with root cause and corrective/preventive actions  Growth Promotion of media after incubation  Record of activities and occurrences during the APS  Any deviations/OOS  A Final Report which evaluates the entire media fill and formulates a conclusion on the acceptability of the APS is required.  Quality unit oversight of the entire process including observation in real time
  • 14. ASEPTIC PROCESS SIMULATION (MEDIA FILL) POINTS TO CONSIDER FOR APS 1. Number of APS – for new line/process a minimum of three (3) APS are required. For ongoing requalification – minimum semi-annual. If different processes are performed on the same line, each process has to be re-evaluated semi-annually. 2. Container closure – if multiple sizes of containers of the same type and in same process are used, a bracketing approach (smallest-largest) may be used. 3. Filling speed-generally should be set at production filling range. However if higher or lower speeds present “worst case” conditions those maybe used. Eg. Bracketing approach of highest speed with smallest unit (operational challenge-PM generation) or slowest speed with largest vial (larger neck size – maximum exposure) may be used.
  • 15. ASEPTIC PROCESS SIMULATION (MEDIA FILL) 4. Fill volume- container need not be filled to full capacity. Amount of media should be sufficient to contact all container –closure surfaces when inverted and allow for detection of microbial growth. 5. Media used – most common medium used is Soybean Casein Digest Medium (SCDM). This medium is capable of supporting the growth of aerobic microorganisms commonly found in the clean room environment and personnel samples. If the process being validated is anaerobic then Fluid Thioglycollate Medium (FTM) may be used. 6. Inert gassing – Typically Nitrogen or other inert gases are used to protect oxygen-sensitive products and also to provide positive pressure for transfer. For APS the Nitrogen should be replaced by air using the same method of delivery and at the same steps.
  • 16. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Duration and number of units filled – the duration should simulate the longest fill or be representative of routine operations. The duration should be sufficient to allow all interventions and process steps to be executed. Number of units filled during APS should be based on contamination risk and sufficient to simulate the process. Generally 5,000-10,000 units are considered acceptable for average production runs.  For production batches less than 5,000 units, the APS batch should be equal to the production batch size.  For production batches 5,000 to 10,000 units, the APS batch should be comparable size (5,000-10,000 units).  For production batches >10,000 units, the APS batch should be > 10,000 units with several approaches to the batch size and filling process.
  • 17. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Interventions- Activities performed by personnel in proximity to the aseptic fill zone are called Interventions. Some of these are unavoidable and part of the process. However, Interventions in aseptic processes should be kept to a minimum. The Risk Assessment performed should be used to record and evaluate the contamination risk posed to the product due to each intervention.  Identification of Interventions- the type and frequency of each intervention must be identified. Hence a list of interventions with the frequency of occurrence is to be maintained and re-evaluated.  The interventions are grouped into two categories – inherent (routine) and corrective (non-routine).
  • 18. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Inherent (routine) Interventions-  These are normal planned activities that occur during an aseptic filling process. Some examples are  Equipment set up – aseptic assembly  Fill weight checks and adjustments  Recharging stoppers and other closures  Environmental Monitoring sampling  Shift changes, breaks, duration of personnel activity
  • 19. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Corrective (non-routine) interventions These are performed to correct an aseptic process during execution. They are not a part of the normal aseptic process but they are well defined and recognized as occurring on infrequent occasions. Some examples-  Container breakage and picking up fallen units  Correcting stopper jams  Changing out filling needles or equipment  Pulling samples  Clearing rejected units  Maintenance work – line stoppage  Changing out of filters, tubing, pumps
  • 20. ASEPTIC PROCESS SIMULATION (MEDIA FILL) List and process for Interventions- There should be an approved list of interventions. This list is to be re-evaluated at pre- determined intervals or if any unusual events occur during production runs. There should be established procedures that describe how to perform these interventions. Only personnel trained/qualified in the interventions should be permitted to perform them. During an APS these interventions should be incorporated to represent the type and frequency of each type on the approved list. During routine production operations, any interventions performed should be documented and frequency noted. If any unusual interventions are performed they should be evaluated and a Risk Assessment performed as necessary. Based on the risk/evaluation they should be incorporated into the approved list of interventions for APS.
  • 21. ASEPTIC PROCESS SIMULATION (MEDIA FILL) PROCESS QUALIFICATION Lyophilized Products – most are aseptically filled and then transferred to a pre-sterilized lyophilization chamber and subject to lyophilization. The process of loading the partially stoppered units into the lyophilizer, lyophilization process and the final unloading of the chamber must be captured during an APS. This can be done as follows-  Load /unload with shortened hold time and partial vacuum.  Simulated lyophilization- where the units are held under partial vacuum for the full duration of the cycle.  In both cases sterile air is used to vent the chamber instead of Nitrogen.  APS is used to qualify and requalify the aseptic steps of the lyophilization process.
  • 22. ASEPTIC PROCESS SIMULATION (MEDIA FILL) PERSONNEL QUALIFICATION The requirements and the process for the qualification of personnel should be documented in a procedure and results documented and records maintained per each person. Pre-requisite – all relevant training such as gowning qualification, clean room and aseptic behavior training, GMP training, procedure training, Initial Qualification- Personnel should participate in a successful APS in which they perform activities which they would normally perform. Periodic Qualification- Personnel should participate in a successful APS in which they perform activities which they would normally perform once per year at a minimum. Disqualification can occur if the personnel fail to participate in periodic qualification, fail gown certification repeatedly, participate in a failed APS whose failure was directly attributed to their poor aseptic technique.
  • 23. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Pre-incubation inspection After the completion of the filling and sealing process, the exact unit count is recorded and verified. The units are subject to pre-incubation inspection. The purpose is to remove all non-integral units which would have been removed during normal product inspection. Once again count of units proceeding for incubation is documented and verified. Some examples of units which maybe removed are units with cracks, misaligned or missing stoppers, poor crimps- units with compromised container closures. These would also be removed during routine inspection of product. No unit maybe removed due to cosmetic defects. The number of units removed and the cause should be documented and verified.
  • 24. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Incubation conditions Incubation conditions should be suitable for the recovery of bioburden and environmental isolates. It should be in the range of 20-350 C. Incubation time should be not less than 14 days. A single incubation temperature for 14 days or two temperatures for 7 days each may be used. If two incubation temperatures are used it is recommended to start incubation at the lower temperature. Prior to start of incubation all units should be inverted or manipulated so that the media comes into contact with all internal surfaces.
  • 25. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Post –incubation inspection After completion of incubation, all APS units are inspected visually for the presence of microbial growth. Personnel trained to detect low/high levels and different types of microbial growth should perform the inspection. The count of units is performed and verified after inspection. If non-integral units are found an investigation should be performed as these should have been detected during pre-incubation inspection. All these activities should have the oversight of the Quality unit. Growth Promotion should be performed after final inspection. In addition to ATCC cultures the most common environmental isolates should be used.
  • 26. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Acceptance Criteria The target acceptance criteria for APS study is zero contaminated units. Per FDA Guidance for Aseptic Processing When filling <5000 units – one contaminated unit is cause for revalidation When filling 5000 to 10,000 units- - one contaminated unit – investigation and possible repeat media fill - two contaminated units- revalidation following investigation When filling > 10,000 units- - one contaminated unit – investigation - two contaminated units- revalidation following investigation
  • 27. ASEPTIC PROCESS SIMULATION (MEDIA FILL) Investigation of an APS positive/contamination A thorough investigation should be performed and documented with root cause and corrective/preventive actions clearly identified. At a minimum, the investigation should include the following-  Species level identification of the contaminant and comparison to EM/personnel isolates  Holistic look at all systems and engineering controls  Environmental trend and recovery review  Personnel activities and qualification  Sanitization process review  Review of batch record, sterilization processes and any deviations  Tracing the location of the contaminant and corelating to any interventions  Trend review of previous APS
  • 28. ASEPTIC PROCESS SIMULATION (MEDIA FILL) REFERENCES 1. FDA Guidance for Industry- “Sterile Drug Products Produced by Aseptic Processing – Current Good Manufacturing Practices.” September 2004. 2. PDA Technical Report No. 22 – “Process Simulation for Aseptically Filled Products.” 2011. 3. EU GMP Annex 1: Manufacture of Sterile Medicinal Products. 2009 (EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use)